Will This Crush Medtronic, Inc. (MDT)’s Earnings?

Page 1 of 2

On Tuesday, Medtronic, Inc. (NYSE:MDT) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed kneejerk reaction to news that turns out to be exactly the wrong move.

One of the hardest-hit industries from new taxes under Obamacare has been the medical-device business, with a new 2.3% excise tax hitting Medtronic, Inc. (NYSE:MDT) and its device-making peers. Yet the company has taken steps to minimize the impact from Obamacare on its results. Let’s take an early look at what’s been happening with Medtronic, Inc. (NYSE:MDT) over the past quarter and what we’re likely to see in its quarterly report.

Stats on Medtronic

Analyst EPS Estimate $1.03
Change From Year-Ago EPS 4%
Revenue Estimate $4.39 billion
Change From Year-Ago Revenue 2.1%
Earnings Beats in Past 4 Quarters 2

Source: Yahoo! Finance.

Can Medtronic keep its earnings healthy this quarter?
In recent months, analysts have very modestly marked down their views on Medtronic, Inc. (NYSE:MDT)’s earnings, cutting the April quarter’s estimate by a penny per share and the full-year fiscal 2014 projection by $0.02 per share. The stock, though, has advanced a bit, rising 6% since mid-February.

Medtronic, Inc. (NYSE:MDT)

As the leader in spinal and cardiovascular implants, Medtronic is one of the purest plays on medical devices among big companies. Johnson & Johnson (NYSE:JNJ) certainly has a substantial medical-device business, but it’s part of a much bigger health-care conglomerate that spans over-the-counter consumer products, as well as pharmaceuticals. Abbott Laboratories (NYSE:ABT), meanwhile, also has other major businesses, including its generic drug division and its nutritional products. Not being pure plays leaves Johnson & Johnson (NYSE:JNJ) and Abbott Laboratories (NYSE:ABT) less exposed to the industry’s particular challenges, but it also waters down the growth prospects from medical devices.

Yet Medtronic, Inc. (NYSE:MDT) has suffered from overall industry weakness in the cardiovascular market. Rivals St. Jude Medical, Inc. (NYSE:STJ) and Boston Scientific Corporation (NYSE:BSX) both joined Medtronic in posting substantial declines in their cardiac-rhythm management businesses, with St. Jude seeing a double-digit percentage contraction in pacemaker sales in its most recent quarter. Even as Abbott Laboratories (NYSE:ABT) and Johnson & Johnson (NYSE:JNJ) have been able to overcome weakness in their medical-device divisions because of their business diversity, Medtronic has to make do with its area of expertise.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Picture Perfect: The 6 Smartphones with the Best Cameras

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

The 10 Most Expensive Cruise Ships in the World

The 10 Fastest Supercomputers in the World

The 10 Best Countries for Doing Business 2015

6 Most Expensive Fruits In The World

10 Worst Airlines in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!